130 related articles for article (PubMed ID: 26802873)
1. Effect of estrogen on morphine- and oxycodone-induced antinociception in a female femur bone cancer pain model.
Ono H; Nakamura A; Kanemasa T; Sakaguchi G; Shinohara S
Eur J Pharmacol; 2016 Feb; 773():1-12. PubMed ID: 26802873
[TBL] [Abstract][Full Text] [Related]
2. Enhanced GABAergic synaptic transmission at VLPAG neurons and potent modulation by oxycodone in a bone cancer pain model.
Takasu K; Ogawa K; Nakamura A; Kanbara T; Ono H; Tomii T; Morioka Y; Hasegawa M; Shibasaki M; Mori T; Suzuki T; Sakaguchi G
Br J Pharmacol; 2015 Apr; 172(8):2148-64. PubMed ID: 25521524
[TBL] [Abstract][Full Text] [Related]
3. Differential activation of the μ-opioid receptor by oxycodone and morphine in pain-related brain regions in a bone cancer pain model.
Nakamura A; Hasegawa M; Minami K; Kanbara T; Tomii T; Nishiyori A; Narita M; Suzuki T; Kato A
Br J Pharmacol; 2013 Jan; 168(2):375-88. PubMed ID: 22889192
[TBL] [Abstract][Full Text] [Related]
4. Suppression of the acute upregulation of phosphorylated-extracellular regulated kinase in ventral tegmental area by a μ-opioid receptor agonist is related to resistance to rewarding effects in a mouse model of bone cancer.
Nakamura A; Ono H; Ando A; Hinata M; Niidome K; Omachi S; Sakaguchi G; Shinohara S
J Pharmacol Sci; 2017 Jan; 133(1):9-17. PubMed ID: 28034513
[TBL] [Abstract][Full Text] [Related]
5. Effect of the norepinephrine transporter (NET) inhibition on μ-opioid receptor (MOR)-induced anti-nociception in a bone cancer pain model.
Ono H; Nakamura A; Kanbara T; Minami K; Shinohara S; Sakaguchi G; Kanemasa T
J Pharmacol Sci; 2014; 125(3):264-73. PubMed ID: 24965165
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the antinociceptive profiles of morphine and oxycodone in two models of inflammatory and osteoarthritic pain in rat.
Garcia MM; Goicoechea C; Avellanal M; Traseira S; Martín MI; Sánchez-Robles EM
Eur J Pharmacol; 2019 Jul; 854():109-118. PubMed ID: 30978319
[TBL] [Abstract][Full Text] [Related]
7. Aconitum-Derived Bulleyaconitine A Exhibits Antihypersensitivity Through Direct Stimulating Dynorphin A Expression in Spinal Microglia.
Li TF; Fan H; Wang YX
J Pain; 2016 May; 17(5):530-48. PubMed ID: 26762790
[TBL] [Abstract][Full Text] [Related]
8. Oxycodone-induced analgesic effects in a bone cancer pain model in mice.
Kato A; Minami K; Ito H; Tomii T; Matsumoto M; Orita S; Kihara T; Narita M; Suzuki T
Oncology; 2008; 74 Suppl 1():55-60. PubMed ID: 18758199
[TBL] [Abstract][Full Text] [Related]
9. Comparative pharmacological profiles of morphine and oxycodone under a neuropathic pain-like state in mice: evidence for less sensitivity to morphine.
Narita M; Nakamura A; Ozaki M; Imai S; Miyoshi K; Suzuki M; Suzuki T
Neuropsychopharmacology; 2008 Apr; 33(5):1097-112. PubMed ID: 17593930
[TBL] [Abstract][Full Text] [Related]
10. G protein-gated inwardly rectifying potassium (KIR3) channels play a primary role in the antinociceptive effect of oxycodone, but not morphine, at supraspinal sites.
Nakamura A; Fujita M; Ono H; Hongo Y; Kanbara T; Ogawa K; Morioka Y; Nishiyori A; Shibasaki M; Mori T; Suzuki T; Sakaguchi G; Kato A; Hasegawa M
Br J Pharmacol; 2014 Jan; 171(1):253-64. PubMed ID: 24117458
[TBL] [Abstract][Full Text] [Related]
11. Antinociceptive effect of oxycodone in diabetic mice.
Nozaki C; Saitoh A; Tamura N; Kamei J
Eur J Pharmacol; 2005 Nov; 524(1-3):75-9. PubMed ID: 16256106
[TBL] [Abstract][Full Text] [Related]
12. Morphine, oxycodone, and fentanyl exhibit different analgesic profiles in mouse pain models.
Minami K; Hasegawa M; Ito H; Nakamura A; Tomii T; Matsumoto M; Orita S; Matsushima S; Miyoshi T; Masuno K; Torii M; Koike K; Shimada S; Kanemasa T; Kihara T; Narita M; Suzuki T; Kato A
J Pharmacol Sci; 2009 Sep; 111(1):60-72. PubMed ID: 19729873
[TBL] [Abstract][Full Text] [Related]
13. Estrogen modulation of morphine analgesia of visceral pain in female rats is supraspinally and peripherally mediated.
Ji Y; Murphy AZ; Traub RJ
J Pain; 2007 Jun; 8(6):494-502. PubMed ID: 17383238
[TBL] [Abstract][Full Text] [Related]
14. Pregabalin enhances the antinociceptive effect of oxycodone and morphine in thermal models of nociception in the rat without any pharmacokinetic interactions.
Jokinen V; Lilius TO; Laitila J; Niemi M; Rauhala PV; Kalso EA
Eur J Pain; 2016 Feb; 20(2):297-306. PubMed ID: 26031840
[TBL] [Abstract][Full Text] [Related]
15. The G-protein biased mu-opioid agonist, TRV130, produces reinforcing and antinociceptive effects that are comparable to oxycodone in rats.
Austin Zamarripa C; Edwards SR; Qureshi HN; Yi JN; Blough BE; Freeman KB
Drug Alcohol Depend; 2018 Nov; 192():158-162. PubMed ID: 30261403
[TBL] [Abstract][Full Text] [Related]
16. Morphine, oxycodone, methadone and its enantiomers in different models of nociception in the rat.
Lemberg K; Kontinen VK; Viljakka K; Kylänlahti I; Yli-Kauhaluoma J; Kalso E
Anesth Analg; 2006 Jun; 102(6):1768-74. PubMed ID: 16717324
[TBL] [Abstract][Full Text] [Related]
17. Temperature-dependent enhancement of the antinociceptive effects of opioids in combination with gabapentin in mice.
Neelakantan H; Walker EA
Eur J Pharmacol; 2012 Jul; 686(1-3):55-9. PubMed ID: 22575516
[TBL] [Abstract][Full Text] [Related]
18. Skeletal effects of parathyroid hormone infusion in ovariectomized rats with or without estrogen repletion.
Shen V; Birchman R; Wu DD; Lindsay R
J Bone Miner Res; 2000 Apr; 15(4):740-6. PubMed ID: 10780865
[TBL] [Abstract][Full Text] [Related]
19. Characterization of the antinociceptive effects of oxycodone in diabetic mice.
Nozaki C; Saitoh A; Kamei J
Eur J Pharmacol; 2006 Mar; 535(1-3):145-51. PubMed ID: 16533506
[TBL] [Abstract][Full Text] [Related]
20. Effect of endothelin-A receptor antagonist on mu, delta and kappa opioid receptor-mediated antinociception in mice.
Bhalla S; Zhang Z; Patterson N; Gulati A
Eur J Pharmacol; 2010 Jun; 635(1-3):62-71. PubMed ID: 20303944
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
